Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

CYTARABINE vs DACTINOMYCIN: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

CYTARABINE vs DACTINOMYCIN: Safety Overview

Metric CYTARABINE DACTINOMYCIN
Total FAERS Reports 44,383 2,858
Deaths Reported 9,089 507
Death Rate 20.5% 17.7%
Hospitalizations 17,861 721
Average Patient Age 38.0 yrs 18.8 yrs
% Female Patients 41.2% 65.9%
FDA Approval Date Approved Prior to Jan 1, 1982 Approved Prior to Jan 1, 1982
Manufacturer Sagent Pharmaceuticals Eugia US LLC
Route INTRATHECAL INTRAVENOUS
Marketing Status Discontinued Discontinued